Archived

This content is available here strictly for research, reference, and/or recordkeeping and as such it may not be fully accessible. If you work or study at University of Kentucky and would like to request an accessible version, please use the SensusAccess Document Converter.

US Patent Number

9198981

Publication Date

12-1-2015

Abstract

This invention relates to compounds, composJtwns, and methods for the treatment of traits, diseases and conditions that respond to the modulation of angiogenic growth factor bioavailability or biological activity.

Assignees

University of Kentucky Research Foundation, Lexington, KY (US)

Application Number

11/582,662

Filing Date

10/17/2006

Included in

Ophthalmology Commons

Share

COinS